Jones Financial Companies Lllp Purchases 2,012 Shares of Fresenius Medical Care AG (NYSE:FMS)

Jones Financial Companies Lllp grew its position in Fresenius Medical Care AG (NYSE:FMS) by 80.5% during the fourth quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 4,510 shares of the company’s stock after purchasing an additional 2,012 shares during the period. Jones Financial Companies Lllp’s holdings in Fresenius Medical Care were worth $102,000 at the end of the most recent quarter.

A number of other institutional investors also recently modified their holdings of the company. Smartleaf Asset Management LLC increased its position in shares of Fresenius Medical Care by 192.8% in the fourth quarter. Smartleaf Asset Management LLC now owns 1,224 shares of the company’s stock valued at $28,000 after acquiring an additional 806 shares during the last quarter. US Bancorp DE increased its position in shares of Fresenius Medical Care by 8.6% in the fourth quarter. US Bancorp DE now owns 20,429 shares of the company’s stock valued at $463,000 after acquiring an additional 1,610 shares during the last quarter. QRG Capital Management Inc. increased its position in shares of Fresenius Medical Care by 16.7% in the fourth quarter. QRG Capital Management Inc. now owns 67,973 shares of the company’s stock valued at $1,539,000 after acquiring an additional 9,706 shares during the last quarter. Bank of New York Mellon Corp increased its position in shares of Fresenius Medical Care by 5.8% in the fourth quarter. Bank of New York Mellon Corp now owns 21,951 shares of the company’s stock valued at $497,000 after acquiring an additional 1,205 shares during the last quarter. Finally, Arbor Investment Advisors LLC acquired a new stake in shares of Fresenius Medical Care in the fourth quarter valued at about $200,000. 8.37% of the stock is currently owned by institutional investors.

Fresenius Medical Care Price Performance

Shares of NYSE FMS opened at $24.04 on Monday. The business’s 50 day moving average price is $23.67 and its two-hundred day moving average price is $22.21. The company has a market cap of $14.10 billion, a PE ratio of 19.86, a price-to-earnings-growth ratio of 0.76 and a beta of 0.99. The company has a quick ratio of 1.02, a current ratio of 1.37 and a debt-to-equity ratio of 0.42. Fresenius Medical Care AG has a twelve month low of $17.93 and a twelve month high of $25.25.

Analysts Set New Price Targets

FMS has been the topic of a number of recent research reports. StockNews.com raised Fresenius Medical Care from a “hold” rating to a “strong-buy” rating in a research report on Wednesday, February 5th. Truist Financial boosted their price target on Fresenius Medical Care from $23.00 to $25.00 and gave the stock a “hold” rating in a research report on Monday, January 6th. Finally, Bank of America raised Fresenius Medical Care from an “underperform” rating to a “neutral” rating in a research report on Monday, December 2nd.

Fresenius Medical Care Profile

Fresenius Medical Care AG provides dialysis and related services for individuals with renal diseases in Germany, North America, and internationally. The company offers dialysis treatment and related laboratory and diagnostic services through a network of outpatient dialysis clinics; materials, training, and patient support services comprising clinical monitoring, follow-up assistance, and arranging for delivery of the supplies to the patient's residence; and dialysis services under contract to hospitals in the United States for the hospitalized end-stage renal disease (ESRD) patients and for patients suffering from acute kidney failure.